RHUMBLINE ADVISERS - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$9,979,587
-25.2%
98,955
+0.8%
0.01%
-20.0%
Q2 2023$13,339,234
+132430.9%
98,162
+1.3%
0.02%
+25.0%
Q1 2023$10,065
+21.9%
96,905
+4.0%
0.01%
+9.1%
Q4 2022$8,259
-99.9%
93,173
+3.2%
0.01%0.0%
Q3 2022$7,236,000
-11.0%
90,261
+6.4%
0.01%
-8.3%
Q2 2022$8,127,000
-32.9%
84,869
+4.1%
0.01%
-25.0%
Q1 2022$12,112,000
+11.3%
81,534
+6.3%
0.02%
+23.1%
Q4 2021$10,878,000
+7.4%
76,736
-0.9%
0.01%
-7.1%
Q3 2021$10,127,000
-17.0%
77,407
-12.8%
0.01%
-12.5%
Q2 2021$12,202,000
+5.8%
88,785
+0.6%
0.02%0.0%
Q1 2021$11,530,000
+18.4%
88,291
+1.6%
0.02%
+23.1%
Q4 2020$9,737,000
+48.4%
86,935
+4.2%
0.01%
+30.0%
Q3 2020$6,562,000
-2.7%
83,413
-11.0%
0.01%
-9.1%
Q2 2020$6,747,000
+20.3%
93,722
-4.3%
0.01%
-8.3%
Q1 2020$5,607,000
-48.4%
97,903
+0.7%
0.01%
-33.3%
Q4 2019$10,876,000
+24.1%
97,254
+6.7%
0.02%
+12.5%
Q3 2019$8,767,000
+19.7%
91,182
+6.5%
0.02%
+14.3%
Q2 2019$7,323,000
+5.1%
85,584
+2.2%
0.01%
+7.7%
Q1 2019$6,966,000
+31.2%
83,743
+1.3%
0.01%
+8.3%
Q4 2018$5,308,000
-3.6%
82,686
+19.0%
0.01%
+9.1%
Q3 2018$5,505,000
+8.2%
69,4880.0%0.01%
+10.0%
Q2 2018$5,087,000
+11.7%
69,488
-3.4%
0.01%0.0%
Q1 2018$4,555,000
+24.4%
71,921
+0.1%
0.01%
+42.9%
Q4 2017$3,663,000
+6.3%
71,858
+9.4%
0.01%0.0%
Q3 2017$3,445,000
+4.5%
65,665
+1.4%
0.01%
-12.5%
Q2 2017$3,297,000
+14.2%
64,729
-0.4%
0.01%
+14.3%
Q1 2017$2,887,000
+28.0%
65,005
+27.3%
0.01%
+16.7%
Q4 2016$2,256,000
+7.9%
51,077
-2.2%
0.01%0.0%
Q3 2016$2,091,000
-14.1%
52,208
+2.3%
0.01%
-14.3%
Q2 2016$2,435,000
-1.1%
51,018
-13.1%
0.01%
-12.5%
Q1 2016$2,462,000
+2.0%
58,697
+7.2%
0.01%0.0%
Q4 2015$2,413,000
-5.0%
54,772
+2.9%
0.01%
-11.1%
Q3 2015$2,541,000
-14.9%
53,217
+3.9%
0.01%
-10.0%
Q2 2015$2,985,000
+14.0%
51,222
-1.2%
0.01%
+25.0%
Q1 2015$2,618,000
+13.8%
51,847
+1.4%
0.01%
+14.3%
Q4 2014$2,300,000
+23.3%
51,147
+1.0%
0.01%
+16.7%
Q3 2014$1,866,000
-16.2%
50,642
+0.4%
0.01%
-14.3%
Q2 2014$2,227,000
-1.5%
50,442
-3.1%
0.01%0.0%
Q1 2014$2,262,000
-0.7%
52,068
-2.9%
0.01%0.0%
Q4 2013$2,279,000
+19.1%
53,628
-4.7%
0.01%
+16.7%
Q3 2013$1,913,000
+7.4%
56,278
-1.3%
0.01%0.0%
Q2 2013$1,782,00057,0270.01%
Other shareholders
CONMED CORP shareholders Q4 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders